Marlene Marisol Perales-Quintana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marlene Marisol Perales-Quintana has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Paula Cordero-Pérez
Liver Unit, Department of Internal Medicine, University Hospital “Dr. José E. González”, Universidad Autónoma de Nuevo León, Monterrey 64460, Nuevo León, Mexico
4 shared publications - Francisco Javier Guzmán-De la Garza
Department of Epidemiological Research Unit and Health Services, Northeast Biomedical Research Center, Mexican Institute for Social Security, San Nicolás de los Garza, Nuevo León, Mexico
3 shared publications - Alma Leticia Saucedo
Laboratorio Nacional de Investigación y Servicio Agroalimentario y Forestal, Universidad Autónoma Chapingo, km 38.5 Carretera México-Texcoco, Chapingo C.P. 56230, Mexico
2 shared publications Concepcion Sanchez-Martinez
Nephrology Department, "Dr. José E. González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico
2 shared publicationsEdelmiro Pérez-Rodríguez
Transplant Service, "Dr. José E. González" University Hospital, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico
2 shared publicationsLiliana Torres-González
Unidad de Hígado, Hospital Universitario "Dr. José E. González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México
2 shared publications
Latest Publications
- Open Access
- 20 January 2026
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 31, e950702
Complete Blood Count in Delayed Graft Function: A Narrative Review
Delayed graft function (DGF) is a common and critical complication following kidney transplantation, marked by acute kidney injury necessitating dialysis within the first postoperative week. Early detection of patients at risk is crucial for optimizing perioperative management and enhancing graft outcomes. While novel biomarkers have been suggested, their clinical application remains limited. This review explores the potential of complete blood count (CBC) parameters and derived indices as cost-effective, accessible alternatives. This narrative review synthesizes findings from studies examining the relationship between CBC parameters - such as hemoglobin, white blood cell count, and platelet count, and hematological indices like neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) - and DGF risk in kidney transplantation. A comprehensive literature search was conducted across major biomedical databases using targeted keywords. Selected studies were analyzed to assess the predictive value, underlying mechanisms, and clinical utility of these parameters. This review highlights a significant association between specific CBC parameters and DGF risk. Notably, low pre- or perioperative hemoglobin levels, significant perioperative hemoglobin drops, elevated pre- or post-transplant NLR, and altered PLR are correlated with increased DGF risk. These associations are thought to reflect underlying pathophysiological mechanisms, including inflammatory responses, ischemia-reperfusion injury, and immune cell activation. However, variability in study design, sampling time points, donor types, and DGF definitions complicates interpretation, underscoring the need for prospective multicenter validation. CBC-derived parameters demonstrate promising associations with DGF risk, particularly low pre-transplant hemoglobin levels and perioperative declines >1.3 g/dL. Preoperative NLR >3.5 and postoperative leukocyte ratios may aid in early graft dysfunction detection. Despite inconsistent evidence for platelet-related indices, further prospective multicenter studies are essential to confirm clinical utility and establish standardized cutoff values.
- 20 January 2026
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 31, e950702
Open AccessComplete Blood Count in Delayed Graft Function: A Narrative Review
Delayed graft function (DGF) is a common and critical complication following kidney transplantation, marked by acute kidney injury necessitating dialysis within the first postoperative week. Early detection of patients at risk is crucial for optimizing perioperative management and enhancing graft outcomes. While novel biomarkers have been suggested, their clinical application remains limited. This review explores the potential of complete blood count (CBC) parameters and derived indices as cost-effective, accessible alternatives. This narrative review synthesizes findings from studies examining the relationship between CBC parameters - such as hemoglobin, white blood cell count, and platelet count, and hematological indices like neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) - and DGF risk in kidney transplantation. A comprehensive literature search was conducted across major biomedical databases using targeted keywords. Selected studies were analyzed to assess the predictive value, underlying mechanisms, and clinical utility of these parameters. This review highlights a significant association between specific CBC parameters and DGF risk. Notably, low pre- or perioperative hemoglobin levels, significant perioperative hemoglobin drops, elevated pre- or post-transplant NLR, and altered PLR are correlated with increased DGF risk. These associations are thought to reflect underlying pathophysiological mechanisms, including inflammatory responses, ischemia-reperfusion injury, and immune cell activation. However, variability in study design, sampling time points, donor types, and DGF definitions complicates interpretation, underscoring the need for prospective multicenter validation. CBC-derived parameters demonstrate promising associations with DGF risk, particularly low pre-transplant hemoglobin levels and perioperative declines >1.3 g/dL. Preoperative NLR >3.5 and postoperative leukocyte ratios may aid in early graft dysfunction detection. Despite inconsistent evidence for platelet-related indices, further prospective multicenter studies are essential to confirm clinical utility and establish standardized cutoff values.
- Open Access
- 7 January 2025
- Published by Universidad Veracruzana in eNeurobiología
- Vol. 16 (40)
Mecanismos fisiopatológicos de las crisis de ausencia en modelos animales
Las crisis de ausencia son un tipo de epilepsia generalizada caracterizada por una breve pérdida de conciencia y descargas espiga-onda en el electroencefalograma. Estas crisis resultan de una disfunción en el sistema GABAérgico, donde una disminución en la actividad de los receptores GABAA fásicos en la corteza somatosensitiva, junto con un aumento en la inhibición por receptores GABAA tónicos en el circuito tálamo-cortical, facilita estas descargas. En este circuito, el núcleo reticular del tálamo desempeña un papel esencial en el inicio y control de las descargas espiga-onda. Se realizó una búsqueda en bases de datos científicas sobre los mecanismos de generación de estas crisis, el acoplamiento del circuito tálamo-cortical y los modelos animales disponibles. Los modelos genéticos sin daño estructural, como las ratas GAERS y WAG/Rij, han sido fundamentales para el estudio de crisis en circuitos intactos. Sin embargo, los modelos genéticos desmielinizantes, como las ratas tremor y taiep, permiten observar cómo la pérdida de mielina afecta la duración y sincronización de las descargas. La desmielinización no solo incrementa la duración de las descargas, sino que también modifica la dinámica del circuito, subrayando la importancia de estudiar tanto factores estructurales como funcionales en la epilepsia de ausencia y abriendo vías para enfoques terapéuticos más completos. La presente revisión analiza la fisiopatología de las crisis de ausencia, centrándose en los cambios funcionales del circuito tálamo-cortical y la influencia de la desmielinización.
- 7 January 2025
- Published by Universidad Veracruzana in eNeurobiología
- Vol. 16 (40)
Open AccessMecanismos fisiopatológicos de las crisis de ausencia en modelos animales
Las crisis de ausencia son un tipo de epilepsia generalizada caracterizada por una breve pérdida de conciencia y descargas espiga-onda en el electroencefalograma. Estas crisis resultan de una disfunción en el sistema GABAérgico, donde una disminución en la actividad de los receptores GABAA fásicos en la corteza somatosensitiva, junto con un aumento en la inhibición por receptores GABAA tónicos en el circuito tálamo-cortical, facilita estas descargas. En este circuito, el núcleo reticular del tálamo desempeña un papel esencial en el inicio y control de las descargas espiga-onda. Se realizó una búsqueda en bases de datos científicas sobre los mecanismos de generación de estas crisis, el acoplamiento del circuito tálamo-cortical y los modelos animales disponibles. Los modelos genéticos sin daño estructural, como las ratas GAERS y WAG/Rij, han sido fundamentales para el estudio de crisis en circuitos intactos. Sin embargo, los modelos genéticos desmielinizantes, como las ratas tremor y taiep, permiten observar cómo la pérdida de mielina afecta la duración y sincronización de las descargas. La desmielinización no solo incrementa la duración de las descargas, sino que también modifica la dinámica del circuito, subrayando la importancia de estudiar tanto factores estructurales como funcionales en la epilepsia de ausencia y abriendo vías para enfoques terapéuticos más completos. La presente revisión analiza la fisiopatología de las crisis de ausencia, centrándose en los cambios funcionales del circuito tálamo-cortical y la influencia de la desmielinización.
- Open Access
- 15 March 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (3) , e0281381
Metabolic, inflammatory and adipokine differences on overweight/obese children with and without metabolic syndrome: A cross-sectional study
Background: Obesity is associated with low-grade inflammation and metabolic syndrome (MetS) in both children and adults. Our aim was to describe metabolic, inflammatory and adipokine differences on overweight/obese children with and without MetS. Methods: This was an observational study. A total of 107 children and adolescents aged 6–18 years were included. Among this sample, n = 21 had normal body weight, n = 22 had overweight/obesity without MetS, and n = 64 had overweight/obesity with MetS. Anthropometric data and biochemical, adipokine, and inflammatory markers were measured. Different ratios were then assessed for estimate the probability of MetS. ROC analysis was used to estimate the diagnostic accuracy and optimal cutoff points for ratios. Results: Serum CRP levels were higher among children with overweight/obesity with MetS. Adipokines like PAI-1 and leptin were significantly lower in children with normal body weight. The Adipo/Lep ratio was highest in the group with normal body weight. TG/HDL-C and TC/HDL-C ratios were significantly correlated with BMI, DBP, PCR, and PAI-1. TC/HDL-C ratio was significantly correlated with SBP and resistin. TGL/HDL-C ratio was significantly correlated with waist and hip circumferences, fasting glucose, and MCP-1. The AUC for TG/HDL-C at the optimal cutoff of 2.39 showed 85.71% sensitivity and 71.43% specificity. CT/HDL-C at the optimal cutoff of 3.70 showed 65.08% sensitivity and 81.82% specificity. Levels of both ratios increased significantly as additional MetS criteria were fulfilled. Conclusion: Low-grade inflammation is correlated with MetS in children with overweight/obesity. TGL, HDL-C and TGL/HDL-C ratio, obtainable from routine lab tests, allows identification of MetS in children with overweight or obesity.
- 15 March 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (3) , e0281381
Open AccessMetabolic, inflammatory and adipokine differences on overweight/obese children with and without metabolic syndrome: A cross-sectional study
Background: Obesity is associated with low-grade inflammation and metabolic syndrome (MetS) in both children and adults. Our aim was to describe metabolic, inflammatory and adipokine differences on overweight/obese children with and without MetS. Methods: This was an observational study. A total of 107 children and adolescents aged 6–18 years were included. Among this sample, n = 21 had normal body weight, n = 22 had overweight/obesity without MetS, and n = 64 had overweight/obesity with MetS. Anthropometric data and biochemical, adipokine, and inflammatory markers were measured. Different ratios were then assessed for estimate the probability of MetS. ROC analysis was used to estimate the diagnostic accuracy and optimal cutoff points for ratios. Results: Serum CRP levels were higher among children with overweight/obesity with MetS. Adipokines like PAI-1 and leptin were significantly lower in children with normal body weight. The Adipo/Lep ratio was highest in the group with normal body weight. TG/HDL-C and TC/HDL-C ratios were significantly correlated with BMI, DBP, PCR, and PAI-1. TC/HDL-C ratio was significantly correlated with SBP and resistin. TGL/HDL-C ratio was significantly correlated with waist and hip circumferences, fasting glucose, and MCP-1. The AUC for TG/HDL-C at the optimal cutoff of 2.39 showed 85.71% sensitivity and 71.43% specificity. CT/HDL-C at the optimal cutoff of 3.70 showed 65.08% sensitivity and 81.82% specificity. Levels of both ratios increased significantly as additional MetS criteria were fulfilled. Conclusion: Low-grade inflammation is correlated with MetS in children with overweight/obesity. TGL, HDL-C and TGL/HDL-C ratio, obtainable from routine lab tests, allows identification of MetS in children with overweight or obesity.
- Open Access
Metabolomic and biochemical characterization of a new model of the transition of acute kidney injury to chronic kidney disease induced by folic acid
Background: Renal diseases represent a major public health problem. The demonstration that maladaptive repair of acute kidney injury (AKI) can lead to the development of chronic kidney disease (CKD) and end-stage renal disease has generated interest in studying the pathophysiological pathways involved. Animal models of AKI–CKD transition represent important tools to study this pathology. We hypothesized that the administration of multiple doses of folic acid (FA) would lead to a progressive loss of renal function that could be characterized through biochemical parameters, histological classification and nuclear magnetic resonance (NMR) profiling.Methods: Wistar rats were divided into groups: the control group received a daily intraperitoneal (I.P.) injection of double-distilled water, the experimental group received a daily I.P. injection of FA (250 mg kg body weight−1). Disease was classified according to blood urea nitrogen level: mild (40–80 mg dL−1), moderate (100–200 mg dL−1) and severe (>200 mg dL−1). We analyzed through biochemical parameters, histological classification and NMR profiling.Results: Biochemical markers, pro-inflammatory cytokines and kidney injury biomarkers differed significantly (P< 0.05) between control and experimental groups. Histology revealed that as damage progressed, the degree of tubular injury increased, and the inflammatory infiltrate was more evident. NMR metabolomics and chemometrics revealed differences in urinary metabolites associated with CKD progression. The main physiological pathways affected were those involved in energy production and amino-acid metabolism, together with organic osmolytes. These data suggest that multiple administrations of FA induce a reproducible model of the induction of CKD. This model could help to evaluate new strategies for nephroprotection that could be applied in the clinic.
Open AccessMetabolomic and biochemical characterization of a new model of the transition of acute kidney injury to chronic kidney disease induced by folic acid
Background: Renal diseases represent a major public health problem. The demonstration that maladaptive repair of acute kidney injury (AKI) can lead to the development of chronic kidney disease (CKD) and end-stage renal disease has generated interest in studying the pathophysiological pathways involved. Animal models of AKI–CKD transition represent important tools to study this pathology. We hypothesized that the administration of multiple doses of folic acid (FA) would lead to a progressive loss of renal function that could be characterized through biochemical parameters, histological classification and nuclear magnetic resonance (NMR) profiling.Methods: Wistar rats were divided into groups: the control group received a daily intraperitoneal (I.P.) injection of double-distilled water, the experimental group received a daily I.P. injection of FA (250 mg kg body weight−1). Disease was classified according to blood urea nitrogen level: mild (40–80 mg dL−1), moderate (100–200 mg dL−1) and severe (>200 mg dL−1). We analyzed through biochemical parameters, histological classification and NMR profiling.Results: Biochemical markers, pro-inflammatory cytokines and kidney injury biomarkers differed significantly (P< 0.05) between control and experimental groups. Histology revealed that as damage progressed, the degree of tubular injury increased, and the inflammatory infiltrate was more evident. NMR metabolomics and chemometrics revealed differences in urinary metabolites associated with CKD progression. The main physiological pathways affected were those involved in energy production and amino-acid metabolism, together with organic osmolytes. These data suggest that multiple administrations of FA induce a reproducible model of the induction of CKD. This model could help to evaluate new strategies for nephroprotection that could be applied in the clinic.
- 16 October 2018
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 25 (31) , 3719-3747
Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis
Chronic kidney disease (CKD) is a progressive condition characterized by a permanent and irreversible loss of renal function. In accordance to international guidelines, CKD clinical diagnosis methods are based on creatinine and albumin levels and glomerular filtration rate. Unfortunately, these parameters are scarcely affected in early stages, and its inherent intrinsic variability only allows for the identification of intermediate and advanced stages, when life expectancy has become shorter and treatment poses a significant financial investment. In this context, several targeted strategies have been designed for searching novel markers. Among them, "omics" techniques have emerged, mainly based on proteomics and metabolomics research. Urine and serum samples have been selected as starting material to conduct the identification of new CKD biomarkers, capable of differentiating between stages and predicting progression outcomes. In many cases, the principal objective is to develop a fast and reliable clinical method for non-invasive analysis in the early progression stages of the disease. On the other hand, significant efforts have been directed to identify molecules related to the CKD end stage in order to adequate therapies, reduce impairments, and have a positive impact on survival rate. In this article, the state of the art of novel proposed biomarkers for CKD identification is reviewed, with the aim of underlining its molecular diversity, emphasizing chemical structure differences and correlating its biological relevance. Efforts directed in this line could provide evidence of metabolic pathways imbalance, and lead to the development of new integral strategies for CKD evaluation and management.
- 16 October 2018
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 25 (31) , 3719-3747
Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis
Chronic kidney disease (CKD) is a progressive condition characterized by a permanent and irreversible loss of renal function. In accordance to international guidelines, CKD clinical diagnosis methods are based on creatinine and albumin levels and glomerular filtration rate. Unfortunately, these parameters are scarcely affected in early stages, and its inherent intrinsic variability only allows for the identification of intermediate and advanced stages, when life expectancy has become shorter and treatment poses a significant financial investment. In this context, several targeted strategies have been designed for searching novel markers. Among them, "omics" techniques have emerged, mainly based on proteomics and metabolomics research. Urine and serum samples have been selected as starting material to conduct the identification of new CKD biomarkers, capable of differentiating between stages and predicting progression outcomes. In many cases, the principal objective is to develop a fast and reliable clinical method for non-invasive analysis in the early progression stages of the disease. On the other hand, significant efforts have been directed to identify molecules related to the CKD end stage in order to adequate therapies, reduce impairments, and have a positive impact on survival rate. In this article, the state of the art of novel proposed biomarkers for CKD identification is reviewed, with the aim of underlining its molecular diversity, emphasizing chemical structure differences and correlating its biological relevance. Efforts directed in this line could provide evidence of metabolic pathways imbalance, and lead to the development of new integral strategies for CKD evaluation and management.
- Open Access
- 1 January 2018
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 9572803
Nephroprotective Effect of Sonchus oleraceus Extract against Kidney Injury Induced by Ischemia‐Reperfusion in Wistar Rats
Introduction. Kidney ischemia‐reperfusion (I/R) injury is the main cause of delayed graft function in solid organ transplantation. Sonchus oleraceus is a plant with well‐known antioxidant and anti‐inflammatory activities; however, its effects on renal I/R are unknown. Objective. To evaluate whether S. oleraceus extract (S.O.e.) has nephroprotective activity in an I/R model in Wistar rats. Materials and Methods. Animal groups (n = 6): sham, I/R (45 min/15 h), S.O.e (300 mg/kg p.o.), and S.O.e + I/R (300 mg/kg, p.o.; 45 min/15 h). Renal function, proinflammatory cytokines, alanine aminotransferase, markers of oxidative stress, and histology were evaluated. Results. None of the mediators evaluated differed significantly between the S.O.e and sham groups. Levels of blood urea nitrogen (BUN), creatinine, malondialdehyde (MDA), and proinflammatory cytokines were higher, and superoxide dismutase (SOD) was lower in the I/R group than in the sham group. Histology showed tubular epithelial necrosis in the medulla and cortex in the I/R group. In the S.O.e + I/R group, S.O.e pretreatment attenuated the I/R‐induced increases in BUN, creatinine, MDA, and proinflammatory cytokines induced, SOD was maintained, and histology showed discontinuous necrosis in the medulla but no necrosis in the cortex. Conclusions. S.O.e was neither hepatotoxic nor nephrotoxic. S.O.e. pretreatment showed a nephroprotective effect against I/R.
- 1 January 2018
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 9572803
Open AccessNephroprotective Effect of Sonchus oleraceus Extract against Kidney Injury Induced by Ischemia‐Reperfusion in Wistar Rats
Introduction. Kidney ischemia‐reperfusion (I/R) injury is the main cause of delayed graft function in solid organ transplantation. Sonchus oleraceus is a plant with well‐known antioxidant and anti‐inflammatory activities; however, its effects on renal I/R are unknown. Objective. To evaluate whether S. oleraceus extract (S.O.e.) has nephroprotective activity in an I/R model in Wistar rats. Materials and Methods. Animal groups (n = 6): sham, I/R (45 min/15 h), S.O.e (300 mg/kg p.o.), and S.O.e + I/R (300 mg/kg, p.o.; 45 min/15 h). Renal function, proinflammatory cytokines, alanine aminotransferase, markers of oxidative stress, and histology were evaluated. Results. None of the mediators evaluated differed significantly between the S.O.e and sham groups. Levels of blood urea nitrogen (BUN), creatinine, malondialdehyde (MDA), and proinflammatory cytokines were higher, and superoxide dismutase (SOD) was lower in the I/R group than in the sham group. Histology showed tubular epithelial necrosis in the medulla and cortex in the I/R group. In the S.O.e + I/R group, S.O.e pretreatment attenuated the I/R‐induced increases in BUN, creatinine, MDA, and proinflammatory cytokines induced, SOD was maintained, and histology showed discontinuous necrosis in the medulla but no necrosis in the cortex. Conclusions. S.O.e was neither hepatotoxic nor nephrotoxic. S.O.e. pretreatment showed a nephroprotective effect against I/R.
- Open Access
- 21 December 2015
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2016 (1) , 3196431
Spironolactone Effect in Hepatic Ischemia/Reperfusion Injury in Wistar Rats
Introduction. Ischemia/reperfusion (IR) injury, often associated with liver surgery, is an unresolved problem in the clinical practice. Spironolactone is an antagonist of aldosterone that has shown benefits over IR injury in several tissues, but its effects in hepatic IR are unknown. Objective. To evaluate the effect of spironolactone on IR‐induced damage in liver. Materials and Methods. Total hepatic ischemia was induced in rats for 20 min followed by 60 min of reperfusion. Spironolactone was administered and hepatic injury, cytokine production, and oxidative stress were assessed. Results. After IR, increased transaminases levels and widespread acute inflammatory infiltrate, disorganization of hepatic hemorrhage trabeculae, and presence of apoptotic bodies were observed. Administration of SPI reduced biochemical and histological parameters of liver injury. SPI treatment increased IL‐6 levels when compared with IR group but did not modify either IL‐1β or TNF‐α with respect to IR group. Regarding oxidative stress, increased levels of catalase activity were recorded in IR + SPI group in comparison with group without treatment, whereas MDA levels were similar in IR + SPI and IR groups. Conclusions. Spironolactone reduced the liver damage induced by IR, and this was associated with an increase in IL‐6 production and catalase activity.
- 21 December 2015
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2016 (1) , 3196431
Open AccessSpironolactone Effect in Hepatic Ischemia/Reperfusion Injury in Wistar Rats
Introduction. Ischemia/reperfusion (IR) injury, often associated with liver surgery, is an unresolved problem in the clinical practice. Spironolactone is an antagonist of aldosterone that has shown benefits over IR injury in several tissues, but its effects in hepatic IR are unknown. Objective. To evaluate the effect of spironolactone on IR‐induced damage in liver. Materials and Methods. Total hepatic ischemia was induced in rats for 20 min followed by 60 min of reperfusion. Spironolactone was administered and hepatic injury, cytokine production, and oxidative stress were assessed. Results. After IR, increased transaminases levels and widespread acute inflammatory infiltrate, disorganization of hepatic hemorrhage trabeculae, and presence of apoptotic bodies were observed. Administration of SPI reduced biochemical and histological parameters of liver injury. SPI treatment increased IL‐6 levels when compared with IR group but did not modify either IL‐1β or TNF‐α with respect to IR group. Regarding oxidative stress, increased levels of catalase activity were recorded in IR + SPI group in comparison with group without treatment, whereas MDA levels were similar in IR + SPI and IR groups. Conclusions. Spironolactone reduced the liver damage induced by IR, and this was associated with an increase in IL‐6 production and catalase activity.